Hrt Financial LP Cabaletta Bio, Inc. Transaction History

Hrt Financial LP

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 09, 2024	BUY	$12.21 - $23.36 $170,427 - $326,058	13,958 New	13,958 $316,000
Q1 2023 May 12, 2023	BUY	$7.08 - $12.62 $709,585 - $1.26 Million	100,224 New	100,224 $828,000
Q4 2021 Feb 14, 2022	SELL	$3.36 - $14.64 $85,068 - $370,655	-25,318 Closed	0 $0
Q3 2021 Nov 15, 2021	SELL	$7.0 - $12.5 $84,371 - $150,662	-12,053 Reduced 32.25%	25,318 $307,000
Q2 2021 Aug 16, 2021	BUY	$7.2 - $11.73 $269,071 - $438,361	37,371 New	37,371 $321,000

126

47.9M

202K

110K

Ticker CABA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 29,014,000
Market Cap $66.4M
Description
Cabaletta Bio, Inc., a clinical-stage biotechnology company, focuses on the discovery and development of engineered T cell therapies for patients with B cell-mediated autoimmune diseases. Its proprietary technology utilizes chimeric autoantibody receptor (CAAR) T cells that are designed to selectively bind and eliminate B cells, which produce di...

Get notified when there are updates to the investment portfolio of Hrt Financial LP, based on Form 13F filings with the SEC.

Stay updated on Hrt Financial LP with notifications on news.